The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology license.

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Early, integrated treatment for first-episode psychosis reduces long-term illness, limits symptoms, boosts recovery, and ...

Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

The "Prion Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been added to ResearchAndMarkets.com's offering. This Prion ...

He showed marked improvement with risperidone 6 mg nocte, chlorpromazine 50 mg nocte and fluvoxamine of 200 mg nocte. The need of comprehensive treatments to modify his stroke risk factors was ...

risperidone, quetiapine, valproate and lithium). Dysautonomia is a common occurrence in PD and is probably due to the neurodegenerative disease process itself taking place inside either the CNS or ...

Teva Pharmaceutical Industries Limited ( NYSE: TEVA) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 11:15 AM ET Richard Francis - President and CEO Eric Hughes - Head of R&D and Chief ...